— Know what they know.
Not Investment Advice
Also trades as: GLS (NYSE) · $vol 0M · GLS-WT (NYSE) · $vol 0M

GLSHQ OTC

Gelesis Holdings, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $7334 mcap · 35M float · 0.0006% daily turnover · Short 7% of daily vol

Cash Flow Trends

Operating Cash Flow
-$78M -40.6% ▼
Capital Expenditures
$9M +54.2% ▲
Free Cash Flow
-$87M -15.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$21M -6.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022
— Operating Activities —
Net Income-$15M-$93M-$56M
Depreciation & Amort.$0$4M$6M
Stock-Based Comp.$0$6M$30M
Change in Working Capital$2M$19M-$7M
Other Non-Cash Items$13M$750K-$50M
Operating Cash Flow-$861K-$55M-$78M
— Investing Activities —
Capital Expenditures$0-$20M-$9M
Acquisitions (Net)$0$0$0
Investment Purchases-$276M$0$0
Investment Sales$0$24M$0
Other Investing$0$24M$0
Investing Cash Flow-$276M$4M-$9M
— Financing Activities —
Net Debt Issuance$0$32M-$4M
Stock Repurchased$0$0$0
Dividends Paid$0$0$0
Other Financing$277M$156K$71M
Financing Cash Flow$277M$33M$66M
Net Change in Cash$492K-$20M-$21M
Cash End of Period$492K$28M$7M
Free Cash Flow-$861K-$75M-$87M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms